CN1159336C - Technological process of producing Fludrocortisone 6 alpha F - Google Patents

Technological process of producing Fludrocortisone 6 alpha F Download PDF

Info

Publication number
CN1159336C
CN1159336C CNB00136586XA CN00136586A CN1159336C CN 1159336 C CN1159336 C CN 1159336C CN B00136586X A CNB00136586X A CN B00136586XA CN 00136586 A CN00136586 A CN 00136586A CN 1159336 C CN1159336 C CN 1159336C
Authority
CN
China
Prior art keywords
reaction
ester
ketenes
reaction solution
reaction liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB00136586XA
Other languages
Chinese (zh)
Other versions
CN1361110A (en
Inventor
李金禄
王福军
付锡珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIANJIN PHARMACEUTICAL INDUSTRY GROUP CORP Ltd
Original Assignee
TIANJIN PHARMACEUTICAL INDUSTRY GROUP CORP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN PHARMACEUTICAL INDUSTRY GROUP CORP Ltd filed Critical TIANJIN PHARMACEUTICAL INDUSTRY GROUP CORP Ltd
Priority to CNB00136586XA priority Critical patent/CN1159336C/en
Publication of CN1361110A publication Critical patent/CN1361110A/en
Application granted granted Critical
Publication of CN1159336C publication Critical patent/CN1159336C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method of the production technology of fluocinolone acetonide 6 alphaF. An intermediate body, namely enol ester, is used as raw material. Perchloryl fluoride is used for fluorination reaction, 40% to 70% of Na2HPO4 water solutions are added into reaction liquid for neutralizing acidic material after reaction, the pH value of the reaction liquid is stable and is maintained between 6 and 8; after the reaction is finished, the reaction liquid is concentrated and crystallized, is diluted by lots of water, is filtered, and is dried; the reaction liquid is recrystallized, is refined, and is dissolved by the solvent of 7 parts of chloroform and 3 parts of methanol; methanol is poured at the later period of concentration, the reaction liquid is recrystallized in the methanol, and 6 alphaF substances are obtained through filtration and dryness. The technology can enhance the yield and the quality of the 6 alphaF substances, and decrease impurity content in the 6 alphaF substances.

Description

The producing and manufacturing technique of fluocinonide 6 α F
Technical field:
The present invention relates to the production technique of fluocinonide 6 α F (6-α F ketenes ester).
Background technology:
The production technique of traditional fluocinonide 6-α F ketenes ester is a raw material with the intermediate enol ester; Carry out fluoride reaction with perchloryl fluoride, after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing.Its shortcoming is that pH value progressively reduces in reaction process, causes reaction unstable, and quality and yield are not high.
Summary of the invention:
The present invention is directed to the problem that prior art exists, a kind of producing and manufacturing technique of fluocinonide 6-α F ketenes ester is provided, is raw material with the intermediate enol ester; Carry out fluoride reaction with perchloryl fluoride,
Figure C0013658600031
In reaction solution, add 40~70% Na 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction make the pH value of reaction solution stable, maintain between 6~8, react.Because pH value is stable in the reaction process, and product quality and yield are improved.
In order to realize purpose of the present invention, the invention provides following technical scheme:
With the intermediate enol ester is raw material; Carry out fluoride reaction with perchloryl fluoride, in reaction solution, add 40~70% Na 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction make the pH value of reaction solution stable, maintain between 6~8, and after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing.
Excellent beneficial effect of the present invention can be confirmed by following experiment effect.
Table 1: the production technique of fluocinonide 6-α F ketenes ester thing of the present invention and prior art effect are relatively
Numbering Enol ester is criticized charging capacity kg Production method 6-α F ketenes ester produce amount kg Yield % Improve yield % Content % Improve content %
1 30 Prior art 23.4 78.0 0 88 0
2 30 Add 15kg Na 2HPO 4 24.9 83.0 6.4 90 2.3
3 30 Add 18kg Na 2HPO 4 25.1 83.7 7.2 91 3.4
4 30 Add 21kg Na 2HPO 4 25.1 83.7 7.2 90 2.3
Annotate: yield %=6-α F ketenes ester produce amount ÷ enol ester is criticized charging capacity * 100%
Improve yield %=(6-α F ketenes ester produce amount-contrast 6-α F ketenes ester produce amount) ÷ contrast 6-α F ketenes ester produce amount * 100%
Improve content %=(6-α F ketenes ester thing content-contrast 6-α F ketenes ester thing content) ÷ contrast 6-α F ketenes ester thing content * 100%
Above sample is that 7: 3 benzene and ethyl ester mixed solvent made developping agent with volume ratio through the chromatography chromatogram relatively, clearly adds Na 2HPO 4The impurity of product be less than and do not add Na 2HPO 4Product.
As can be seen from the above table: the Na of adding 40~70% 2HPO 4The aqueous solution can make 6-α F ketenes ester thing yield content obviously improve, simultaneously when adding Na 2HPO 4It is little that the aqueous solution is lower than 40% o'clock increase rate, adds Na 2HPO 4The aqueous solution 40~70% increase rates are basic identical.
This shows that excellent beneficial effect of the present invention is:
In reaction solution, add 40~70% Na 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction make the pH value of reaction solution stable, maintain between 6~8, react.Because pH value is stable in the reaction process, and product quality and yield are improved.
Embodiment:
Embodiment 1:
Use enol ester 30kg; Add 400kg acetone, carry out fluoride reaction with the 24kg perchloryl fluoride, after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing 23.4kg, content 88%.
Embodiment 2:
Use enol ester 30kg; Add 400kg acetone, carry out fluoride reaction, in reaction solution, add 15kgNa with the 24kg perchloryl fluoride 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction are surveyed pH value=6.5, and after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing 24.9kg, content 90%.
Embodiment 3:
Use enol ester 30kg; Add 400kg acetone, carry out fluoride reaction, in reaction solution, add 18kgNa with the 24kg perchloryl fluoride 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction are surveyed pH value=7.0, and after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing 25.1kg, content 91%.
Embodiment 4:
Use enol ester 30kg; Add 400kg acetone, carry out fluoride reaction, in reaction solution, add 21kgNa with the 24kg perchloryl fluoride 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction are surveyed pH value=7.0, and after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing 25.1kg, content 90%.

Claims (1)

1. the producing and manufacturing technique of a fluocinonide 6-α F ketenes ester, it is characterized in that: with the intermediate enol ester is raw material, carries out fluoride reaction with perchloryl fluoride, adds 40~70% Na in reaction solution 2HPO 4The acidic substance of the aqueous solution after with neutralization reaction make the pH value of reaction solution stable, maintain between 6~8, and after reaction finished, the reaction solution condensing crystal passed through big water gaging dilution, filtration, drying successively; Carrying out recrystallizing and refining again, is that 7: 3 chloroform and methanol mixed solvent dissolves with volume ratio; Concentrate, the later stage is poured methyl alcohol; Carry out recrystallization in methyl alcohol, filter, drying gets 6-α F ketenes ester thing.
CNB00136586XA 2000-12-27 2000-12-27 Technological process of producing Fludrocortisone 6 alpha F Expired - Fee Related CN1159336C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB00136586XA CN1159336C (en) 2000-12-27 2000-12-27 Technological process of producing Fludrocortisone 6 alpha F

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB00136586XA CN1159336C (en) 2000-12-27 2000-12-27 Technological process of producing Fludrocortisone 6 alpha F

Publications (2)

Publication Number Publication Date
CN1361110A CN1361110A (en) 2002-07-31
CN1159336C true CN1159336C (en) 2004-07-28

Family

ID=4597372

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00136586XA Expired - Fee Related CN1159336C (en) 2000-12-27 2000-12-27 Technological process of producing Fludrocortisone 6 alpha F

Country Status (1)

Country Link
CN (1) CN1159336C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300167C (en) * 2005-03-02 2007-02-14 天津太平洋化学制药有限公司 Process for producing fluocinone intermediate 6aF
CN101397318B (en) * 2007-09-29 2011-05-18 天津天药药业股份有限公司 Technique for refining fluocinonide 9 fluorine

Also Published As

Publication number Publication date
CN1361110A (en) 2002-07-31

Similar Documents

Publication Publication Date Title
CN1158300C (en) Process for producing drospirenone (6 beta, 7 beta, 15 beta, 16 beta-dimethylene-3-oxo-17 alpha-pregn-4-en-21, 17-carbolactone, <u> DRSP <1u>)
EP0703927A1 (en) Preparation of polycarboxylates based on polysaccharides
DE3345445A1 (en) METHOD FOR PURIFYING ANTHRACYCLINONE GLYCOSIDES BY SELECTIVE ADSORPTION ON RESIN
CN1159336C (en) Technological process of producing Fludrocortisone 6 alpha F
CN104892508A (en) Purification method for cisatracurium besylate
CN1264855C (en) Process for production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21- dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
EP0312726B1 (en) Optically active salt of a substituted thiazolidine-4-carboxylic acid and a 3-chlor-2-hydroxypropyl trimethyl ammonium, their preparation and use
CN104292161B (en) A kind of process for purification along atracurium besilate
DE102006053594A1 (en) Process for the purification of letrozole
CN111777654B (en) Preparation method of prednisone
CN109134331B (en) Synthesis method of azithromycin genotoxic impurity
EP0075262A2 (en) Process for the preparation of 5-ribo nucleotides
CN105111254A (en) Extraction method of lincomycin
CN1300167C (en) Process for producing fluocinone intermediate 6aF
CN1142176C (en) Halcinonide producing process
DE2638555A1 (en) METHOD FOR MANUFACTURING PANTETHIN
CN106397529A (en) Method used for extracting and separating maslinic acid from olea europaea L. pomace
CH641140A5 (en) METHOD FOR PRODUCING A SALT OF PYRUVINIC ACIDS.
DE19823062A1 (en) Process for producing an alkyl glycoside
CN115448963A (en) Preparation method of N-acetyl-D-glucosamine
CN107793446A (en) A kind of purification process of SILVER REAGENT tributyl phosphate
WO2007079736A1 (en) Method for producing dimethylaminoarglabin hydrochloride
DE2225797A1 (en)
DE2857509C2 (en) Process for the preparation of N-methylmoranoline
CN116751121A (en) Preparation method of high-purity potassium acetate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Tianjin Pharmaceutical Industry Group Corp., Ltd.

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice

Addressee: Tianjin Pharmaceutical Industry Group Corp., Ltd.

Document name: Notification of Termination of Patent Right

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040728

Termination date: 20111227